Equitable Trust’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
CIP
Equitable Trust's RGEN Position: Q2 2025 in Review
Equitable Trust sold out of Repligen (RGEN) in Q2 2025, closing a stake of 2,577 shares — an estimated $328K sold.
Equitable Trust first reported a position in RGEN in Q2 2024 and held it in 4 quarters. The position peaked at $384K in Q3 2024. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.
- Equitable Trust reported no remaining Repligen position as of Q2 2025 after selling out during the quarter.
- Equitable Trust sold 2,577 Repligen shares in Q2 2025, an estimated $328K.
- Equitable Trust first reported a position in Repligen in Q2 2024 and held it in 4 quarters.
- Equitable Trust's Repligen position peaked at $384K in Q3 2024.
- 444 funds tracked by Wall St. Rank held Repligen as of Q2 2025.
Based on Equitable Trust's 13F filing for Q2 2025, filed 23 Jul 2025.